PharVision Advisers’s APi Group APG Stock Holding History

PharVision Advisers’s Portfolio APG Stock Details APG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,905	Closed	-$235K	–	666
2025 Q2	$235K	Buy	+6,905	New	+$198K	0.34%	157

Other funds holding APG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PharVision Advisers's APG Position: Q3 2025 in Review

PharVision Advisers sold out of APi Group (APG) in Q3 2025, closing a stake of 6,905 shares — an estimated $235K sold.

PharVision Advisers first reported a position in APG in Q2 2025 and held it in 1 quarter. The position peaked at $235K in Q2 2025. 475 funds tracked by Wall St. Rank hold APG as of Q3 2025.

PharVision Advisers reported no remaining APi Group position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 6,905 APi Group shares in Q3 2025, an estimated $235K.
PharVision Advisers first reported a position in APi Group in Q2 2025 and held it in 1 quarter.
PharVision Advisers's APi Group position peaked at $235K in Q2 2025.
475 funds tracked by Wall St. Rank held APi Group as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.